|
Microbiology & Infectious Diseases
The Microbiology & Infectious Diseases Discussion Group (which merges the former Emerging Infectious Diseases & Microbiology and Vaccine Science Discussion Groups) provides a forum for scientists and individuals to convene and discuss emerging issues in the biology, pathogenesis, transmission and management of pressing health issues. The group explores epidemiology, diagnosis, models of infection, toxins, host–pathogen interactions, therapeutic agents, infection control and disease prevention, genomic, proteomic, and structural biological approaches to understanding infectious agents, vaccine development, safety and legislation, recombinant antigens, field and clinical trials, and social implications. Past symposia have focused on a wide range of diseases, including HIV/AIDS, malaria, tuberculosis, dengue, HPV, cancer, aspergillosis, influenza, H1N1, H5N1 and SARS.
The group brings together basic, clinical, academic and industry scientists working on drug and vaccine development, experts in microbiology and infectious disease, as well as local and national public health officials. This offers an opportunity for lively discussion to exchange information and new ideas, establish collaborations, and develop and strengthen cooperation within this broad area.
Past Events
Friday, May 17, 2013 | 8:00 AM - 4:30 PM
Speakers: Myron S. Cohen (UNC School of Medicine), Chris Collins (amfAR, The Foundation for AIDS Research), Michele R. Decker (Johns Hopkins Bloomberg School of Public Health), Tim Horn (Treatment Action Group), Rick King (IAVI), Luiz Loures (UNAIDS), Mary A. Marovich (NIAID), Nelson L. Michael (Walter Reed Army Institute of Research), Julio Montaner (BC Centre for Excellence in HIV / AIDS), John P. Moore (Weill Cornell Medical College), Robert R. Redfield (University of Maryland School of Medicine), Bill Snow (Global HIV Vaccine Enterprise), Magdalena Sobieszczyk (Columbia University Medical Center), Annie Sparrow (Mount Sinai Global Health), Daniel Tietz (ACRIA), Mitchell Warren (AVAC), Jane Waterman (IAVI)
The UNAIDS "three zeros" strategy provides a clear vision for future HIV / AIDS research and policy. This symposium tackles communication and collaboration, capacity-building for HIV prevention, care, and treatment, vaccine trials and a case study.
Monday, March 4, 2013 | 12:00 PM - 4:00 PM
Speakers: Christopher D. Hillyer (New York Blood Center), Jeanne V. Linden (New York State Department of Health), Jeffrey McCullough (University of Minnesota Medical School), Lyle R. Petersen (Centers for Disease Control and Prevention), and Andreas Buser (University Hospital, Basel, Switzerland)
While the blood supply in developed countries is relatively safe, infections and diseases may enter the blood supply from developing countries. We examine strategies for defending the blood supply, including pathogen inactivation technologies.
Wednesday, April 4, 2012 | 5:30 PM - 7:30 PM
Organizers: S. Marvin Friedman (Hunter College, CUNY), Jennifer S. Henry (The New York Academy of Sciences)
Speakers: Bonnie Bassler (Howard Hughes Medical Institute and Princeton University), Arturo Casadevall (Albert Einstein College of Medicine)
Research into obscure organisms can aid drug development from unexpected angles. Speakers discuss the use of quorum sensing to develop anti-microbial agents, and a potential therapy for human melanoma discovered in the study of fungal melanin.
Friday, February 17, 2012 | 2:30 PM - 5:00 PM
Organizers: Barry Kreiswirth (Public Health Research Institute, UMDNJ–NJMS), David S. Perlin (Public Health Research Institute, UMDNJ–NJMS), Issar Smith (Public Health Research Institute, UMDNJ–NJMS), Jennifer Henry (The New York Academy of Sciences)
Speakers: Robert Bonomo (Case Western Reserve University), Barry Kreiswirth (Public Health Research Institute, UMDNJ–NJMS), Thomas J. Walsh (NY Presbyterian Hospital/Weill Cornell)
The global emergence of carbapenem resistant Enterobacteriaceae presents clinical challenges. This symposium examines the molecular epidemiology of carbapenem resistance and the issues that confound the diagnosis and treatment of infected patients.
Thursday, February 9, 2012 | 5:00 PM - 7:30 PM
Organizers: Elizabeth Boon (Stony Brook University), Lorrence H. Green (Westbury Diagnostics), and Jennifer Henry (The New York Academy of Sciences)
Speakers: Elizabeth Boon (Stony Brook University), Kim Janda (Scripps Research Institute), and Kyu Rhee (Weill Cornell Medical College)
This symposium covers infectious disease at a molecular level, including bacterial 'group behavior,' signal transduction pathways; detection of pathogens, weapons of biological warfare; and the development of practical new medical treatments.
Thursday, February 2, 2012 | 6:00 PM - 8:00 PM
Organizer: Jennifer Henry (The New York Academy of Sciences)
Moderator: W. Ian Lipkin (Center for Infection & Immunity, Columbia University)
Panelists: Arturo Casadevall (Albert Einstein College of Medicine), Laurie Garrett (Council on Foreign Relations), Michael T. Osterholm (Center for Infectious Disease Research and Policy, University of Minnesota), Peter Palese (Mount Sinai School of Medicine), Veronique Kiermer (Nature Publishing Group), Barbara R. Jasny (Science), Alan S. Ruldolph (Defense Threat Reduction Agency), Vincent Racaniello (Columbia University)
Following a government recommendation that Nature and Science authors remove methodological details from recent H5N1 studies, scientists, publishers, and legal experts will explore the censorship and biosecurity issues surrounding this controversy.
Wednesday, October 12, 2011 | 5:30 PM - 7:30 PM
Speakers: Vincent A. Fischetti (The Rockefeller University) and Barry Kreiswirth (UMDNJ)
The unchecked use of antibiotics has compromised their effectiveness, leading to drug resistance. This symposium tackles the issues facing pharma, clinicians and researchers in the development of novel strategies to combat disease-causing bacteria.
Tuesday, March 29, 2011 | 1:00 PM - 5:00 PM
Organizers: Lorrence H. Green (Westbury Diagnostics) and Jennifer Henry (The New York Academy of Sciences)
Routine blood screening protocols test for several common pathogens, but miss others such as XMRV. This symposium will discuss recent advances in the testing and screening of the blood supply as well as suggestions for future directions. Presented as part of the Translational Medicine Initiative.
Monday, January 24, 2011 | 5:30 PM - 7:30 PM
Speakers: Denise A. Galloway (Fred Hutchinson Cancer Research Center) and Charles M. Rice (The Rockefeller University
This mini-symposium will focus on recent advances in our knowledge of two viruses that play a role in the etiology of human cancers by distinctly different mechanisms, human papilloma virus and hepatitis C virus.
Tuesday, November 30, 2010 | 6:00 PM - 8:00 PM
Speakers: Johanna Daily (Albert Einstein College of Medicine), Jayne Raper (New York University School of Medicine) and Honorine Ward (Tufts University School of Medicine)
Backpacking and city living facilitate the spread of parasites through food and water, via pets or through sexual contact. This symposium provides a research update into parasitic diseases, including sleeping sickness, malaria and Cryptosporidium.
Monday, May 24, 2010 | 1:00 PM - 5:30 PM
Organizers: Doris Bucher (New York Medical College), Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium will revisit the 2009 outbreak and examine strategies against future outbreaks. Presented as part of the Translational Medicine Initiative.
Tuesday, May 18, 2010 | 6:00 PM - 7:30 PM
Speakers: Jeffrey I. Gordon (Washington University School of Medicine) and Ramnik Xavier (Massachusetts General Hospital)
Genomic and metabolic foundations of gut host-microbial relationships affect our predisposition to obesity, cardiovascular disease and malnutrition. This meeting explores the microbiome and its role in these important health issues.
Tuesday, April 6, 2010 | 1:00 PM - 5:30 PM
Speakers: Helena Boshoff (NIH), William R. Jacobs, Jr. (Albert Einstein College of Medicine), Carl Nathan (Weill Cornell Medical College), Christopher Sassetti (University of Massachusetts Medical School), and Dirk Schnappinger (Weill Cornell Medical College)
TB kills nearly 2 million people yearly, and now shows drug resistance. This symposium highlights how the genetic information of the pathogen and genetic tools are utilized in the quest for new TB drugs.
Tuesday, March 2, 2010 | 8:30 AM - 5:00 PM
Organizers: Dickson Despommier (Columbia University), Stephen S. Morse (Columbia University Mailman School of Public Health) and Gavin Schmidt (NASA)
Climate change has led to higher rates of emerging infectious diseases worldwide, reemergence of diseases previously under control, and redistribution of diseases across the planet. This symposium examines these complex relationships.
Steering Committee Members
New York Medical College |
University of Medicine & Dentistry of New Jersey |
|
Albert Einstein College of Medicine
|
The Rockefeller University |
Hunter College, CUNY |
Allan Goldberg, PhDAvacyn Pharmaceuticals, Inc. |
Westbury Diagnostics Inc. |
Global Alliance for TB Drug Development |
Public Health Research Institute, UMDNJ |
Columbia University |
Columbia University |
Children's Hospital of Philadelphia |
Public Health Research Institute |
Hunter College, CUNY |
|
Global HIV Vaccine Enterprise
|
Sanofi Pasteur, Lyon |
Sponsors
The Microbiology & Infectious Diseases Discussion Group is proudly supported by:
Mission Partner support for the Frontiers of Science program provided by 
Get more information about how you can sponsor a discussion group.
|
|